Literature DB >> 25274182

Combining one-sample confidence procedures for inference in the two-sample case.

Michael P Fay1, Michael A Proschan1, Erica Brittain1.   

Abstract

We present a simple general method for combining two one-sample confidence procedures to obtain inferences in the two-sample problem. Some applications give striking connections to established methods; for example, combining exact binomial confidence procedures gives new confidence intervals on the difference or ratio of proportions that match inferences using Fisher's exact test, and numeric studies show the associated confidence intervals bound the type I error rate. Combining exact one-sample Poisson confidence procedures recreates standard confidence intervals on the ratio, and introduces new ones for the difference. Combining confidence procedures associated with one-sample t-tests recreates the Behrens-Fisher intervals. Other applications provide new confidence intervals with fewer assumptions than previously needed. For example, the method creates new confidence intervals on the difference in medians that do not require shift and continuity assumptions. We create a new confidence interval for the difference between two survival distributions at a fixed time point when there is independent censoring by combining the recently developed beta product confidence procedure for each single sample. The resulting interval is designed to guarantee coverage regardless of sample size or censoring distribution, and produces equivalent inferences to Fisher's exact test when there is no censoring. We show theoretically that when combining intervals asymptotically equivalent to normal intervals, our method has asymptotically accurate coverage. Importantly, all situations studied suggest guaranteed nominal coverage for our new interval whenever the original confidence procedures themselves guarantee coverage. Published 2014. This article is a U.S. Government work and is in the public domain in the USA.

Entities:  

Keywords:  Behrens-Fisher problem; Confidence distributions; Difference in medians; Exact confidence interval; Fisher's exact test; Kaplan-Meier estimator

Mesh:

Year:  2014        PMID: 25274182      PMCID: PMC4852749          DOI: 10.1111/biom.12231

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  9 in total

1.  Test-based exact confidence intervals for the difference of two binomial proportions.

Authors:  I S Chan; Z Zhang
Journal:  Biometrics       Date:  1999-12       Impact factor: 2.571

2.  Analyzing survival curves at a fixed point in time.

Authors:  John P Klein; Brent Logan; Mette Harhoff; Per Kragh Andersen
Journal:  Stat Med       Date:  2007-10-30       Impact factor: 2.373

3.  Recommended tests for association in 2 x 2 tables.

Authors:  Stian Lydersen; Morten W Fagerland; Petter Laake
Journal:  Stat Med       Date:  2009-03-30       Impact factor: 2.373

4.  Fiducial limits of the parameter of a discontinuous distribution.

Authors:  W L STEVENS
Journal:  Biometrika       Date:  1950-06       Impact factor: 2.445

5.  Efficient network meta-analysis: a confidence distribution approach.

Authors:  Guang Yang; Dungang Liu; Regina Y Liu; Minge Xie; David C Hoaglin
Journal:  Stat Methodol       Date:  2014-09-01

6.  Pointwise confidence intervals for a survival distribution with small samples or heavy censoring.

Authors:  Michael P Fay; Erica H Brittain; Michael A Proschan
Journal:  Biostatistics       Date:  2013-04-30       Impact factor: 5.899

7.  Nonparametric estimation for the difference or ratio of median failure times.

Authors:  J Q Su; L J Wei
Journal:  Biometrics       Date:  1993-06       Impact factor: 2.571

8.  A comparison of reflected versus test-based confidence intervals for the median survival time, based on censored data.

Authors:  E V Slud; D P Byar; S B Green
Journal:  Biometrics       Date:  1984-09       Impact factor: 2.571

9.  Mathematical Foundations for a Theory of Confidence Structures.

Authors:  Michael Scott Balch
Journal:  Int J Approx Reason       Date:  2012-10       Impact factor: 3.816

  9 in total
  10 in total

1.  Association analysis of CYP2C9*3 and phenytoin-induced severe cutaneous adverse reactions (SCARs) in Thai epilepsy children.

Authors:  Supharat Suvichapanich; Jiraphun Jittikoon; Nuanjun Wichukchinda; Wasu Kamchaisatian; Anannit Visudtibhan; Suwat Benjapopitak; Somjai Nakornchai; Wiparat Manuyakorn; Surakameth Mahasirimongkol
Journal:  J Hum Genet       Date:  2015-05-21       Impact factor: 3.172

2.  Safety and efficacy of PfSPZ Vaccine against Plasmodium falciparum via direct venous inoculation in healthy malaria-exposed adults in Mali: a randomised, double-blind phase 1 trial.

Authors:  Mahamadou S Sissoko; Sara A Healy; Abdoulaye Katile; Freda Omaswa; Irfan Zaidi; Erin E Gabriel; Bourama Kamate; Yacouba Samake; Merepen A Guindo; Amagana Dolo; Amadou Niangaly; Karamoko Niaré; Amatigue Zeguime; Kourane Sissoko; Hama Diallo; Ismaila Thera; Kelly Ding; Michael P Fay; Elise M O'Connell; Thomas B Nutman; Sharon Wong-Madden; Tooba Murshedkar; Adam J Ruben; Minglin Li; Yonas Abebe; Anita Manoj; Anusha Gunasekera; Sumana Chakravarty; B Kim Lee Sim; Peter F Billingsley; Eric R James; Michael Walther; Thomas L Richie; Stephen L Hoffman; Ogobara Doumbo; Patrick E Duffy
Journal:  Lancet Infect Dis       Date:  2017-02-16       Impact factor: 25.071

3.  Effect of Anticoagulant Therapy for 6 Weeks vs 3 Months on Recurrence and Bleeding Events in Patients Younger Than 21 Years of Age With Provoked Venous Thromboembolism: The Kids-DOTT Randomized Clinical Trial.

Authors:  Neil A Goldenberg; John M Kittelson; Thomas C Abshire; Marc Bonaca; James F Casella; Rita A Dale; Jonathan L Halperin; Frances Hamblin; Craig M Kessler; Marilyn J Manco-Johnson; Robert F Sidonio; Alex C Spyropoulos; P Gabriel Steg; Alexander G G Turpie; Sam Schulman
Journal:  JAMA       Date:  2022-01-11       Impact factor: 157.335

4.  Short-term oestrogen as a strategy to prevent postpartum depression in high-risk women: protocol for the double-blind, randomised, placebo-controlled MAMA clinical trial.

Authors:  Stinne Høgh; Hanne Kristine Hegaard; Kristina Martha Renault; Eleonora Cvetanovska; Anette Kjærbye-Thygesen; Anders Juul; Camilla Borgsted; Anne Juul Bjertrup; Kamilla Woznica Miskowiak; Mette Skovgaard Væver; Dea Siggaard Stenbæk; Vibeke Høyrup Dam; Elisabeth Binder; Brice Ozenne; Divya Mehta; Vibe G Frokjaer
Journal:  BMJ Open       Date:  2021-12-30       Impact factor: 3.006

5.  Statistical considerations for a trial of Ebola virus disease therapeutics.

Authors:  Michael A Proschan; Lori E Dodd; Dionne Price
Journal:  Clin Trials       Date:  2016-01-14       Impact factor: 2.486

6.  A Phase I, Randomized, Controlled Clinical Study of CC-11050 in People Living With HIV With Suppressed Plasma Viremia on Antiretroviral Therapy (APHRODITE).

Authors:  Afroditi Boulougoura; Erin Gabriel; Elizabeth Laidlaw; Vikram Khetani; Ken Arakawa; Jeanette Higgins; Adam Rupert; Robert J Gorelick; Keith Lumbard; Alice Pau; April Poole; Angela Kibiy; Princy Kumar; Irini Sereti
Journal:  Open Forum Infect Dis       Date:  2019-06-03       Impact factor: 3.835

7.  Effect of Implementing the Out-of-Hospital Traumatic Brain Injury Treatment Guidelines: The Excellence in Prehospital Injury Care for Children Study (EPIC4Kids).

Authors:  Joshua B Gaither; Daniel W Spaite; Bentley J Bobrow; Samuel M Keim; Bruce J Barnhart; Vatsal Chikani; Duane Sherrill; Kurt R Denninghoff; Terry Mullins; P David Adelson; Amber D Rice; Chad Viscusi; Chengcheng Hu
Journal:  Ann Emerg Med       Date:  2020-11-11       Impact factor: 5.721

8.  Confidence intervals for difference in proportions for matched pairs compatible with exact McNemar's or sign tests.

Authors:  Michael P Fay; Keith Lumbard
Journal:  Stat Med       Date:  2020-12-01       Impact factor: 2.497

9.  Functional determinants of protein assembly into homomeric complexes.

Authors:  L Therese Bergendahl; Joseph A Marsh
Journal:  Sci Rep       Date:  2017-07-10       Impact factor: 4.379

10.  Efficacy of FLU-v, a broad-spectrum influenza vaccine, in a randomized phase IIb human influenza challenge study.

Authors:  Olga Pleguezuelos; Emma James; Ana Fernandez; Victor Lopes; Luz Angela Rosas; Adriana Cervantes-Medina; Jason Cleath; Kristina Edwards; Dana Neitzey; Wenjuan Gu; Sally Hunsberger; Jeffery K Taubenberger; Gregory Stoloff; Matthew J Memoli
Journal:  NPJ Vaccines       Date:  2020-03-13       Impact factor: 7.344

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.